Search | IOVS | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies

Charles Clifton Wykoff; Justus G Garweg; Carl Regillo; eric souied; Sebastian Wolf; Dilsher Dhoot; Hansjüergen T Agostini; Andrew Chang; Augustinus Laude; Lidija Kovacic; Lixin Wang; Ying Wang; Emmanuel Bouillaud; David M Brown

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3849. doi:

ARVO Annual Meeting Abstract June 2022

Optical Coherence Tomography Findings in Eyes with Spontaneous Reattachment of Macula-off Traction Retinal Detachments

John E Williamson III; Raziyeh Mahmoudzadeh; Mirataollah Salabati; Rebecca R Soares; Omesh P Gupta; Carl Regillo; Allen C Ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3429 – F0329. doi:

ARVO Annual Meeting Abstract June 2022

Refractive Error Change During Diabetic Macular Edema Treatment: A Post Hoc Analysis of the DRCR Protocol T Trial

Mirataollah Salabati; Raziyeh Mahmoudzadeh; Matthew Starr; Qiang (Ed) Zhang; James Sharpe; Jason Hsu; Allen C Ho; Carl Regillo; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2188 – F0251. doi:

ARVO Annual Meeting Abstract June 2022

Efficacy, durability and safety of KSI-301 antibody biopolymer conjugate in wet AMD – Year 1 primary endpoint results from the pivotal DAZZLE study

Carl Regillo; Jason S Ehrlich; Daniel Janer; Diana V Do; Pablo Velazquez-Martin; Rezi Zawadzki; Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3122. doi:

ARVO Annual Meeting Abstract June 2021

Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 for neovascular AMD (OPTIC Trial)

Brandon Busbee; David S Boyer; Arshad M. Khanani; Charles Clifton Wykoff; Dante Joseph Pieramici; Carl Regillo; Carl J Danzig; Brian C Joondeph; James Major; Carol Hoang; Adam Turpcu; Carol Chung; Szilard Kiss; Mehdi Gasmi; Aaron Osborne

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):352. doi:

ARVO Annual Meeting Abstract June 2021

Retinal Displacement Following Incisional Rhegmatogenous Retinal Detachment Repair

Raziyeh Mahmoudzadeh; Mirataollah Salabati; Yoshihiro Yonekawa; Ajay E Kuriyan; M.Ali Khan; Michael A. Klufas; Sunir J. Garg; Omesh Gupta; Carl Regillo; Michael N. Cohen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3084. doi:

ARVO Annual Meeting Abstract June 2021

Development of cystoid macular edema following rhegmatogenous retinal detachment surgery

Matthew Starr; Louis Cai; Michael Ammar; Luv Patel; Anthony Obeid; Ed Ryan; Claire Ryan; Antonio Capone; Geoffrey Emerson; Daniel Joseph; Dean Eliott; Omesh Gupta; Carl Regillo; Jason Hsu; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3657. doi:

ARVO Annual Meeting Abstract June 2020

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Rishi P Singh; Robin Hamilton; Jeffrey S Heier; Carl Regillo; Mark C Gillies; Georges Weissgerber; Jahangir Alam; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1158. doi:

ARVO Annual Meeting Abstract June 2020

Anatomic and visual outcomes of primary retinal detachment in younger adults: a report from the multicenter Primary Retinal Detachment Outcomes (PRO) Study

Louis Cai; Michael J Ammar; Ed Ryan; Jay Wang; Claire Ryan; Connie M Wu; Matthew Starr; Luv Patel; Antonio Capone; Dean Eliott; Geoffrey Emerson; Daniel Joseph; Omesh Gupta; Carl Regillo; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3710. doi:

ARVO Annual Meeting Abstract June 2020

Retinal Detachment Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty

Durga Borkar; Hannah Levin; Turner David Wibbelsman; Sara Rapuano; Daniel MacKinnon; Allen C Ho; Jason Hsu; Carl Regillo; Brandon Ayres; Kristin Hammersmith; Parveen Nagra; Irving Raber; Christopher Rapuano; Zeba Syed

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3761. doi:

ARVO Annual Meeting Abstract June 2020

Characteristics of Clinical Studies Evaluating Off-Label Indications for Novel FDA-Approved Therapeutics in Ophthalmology

Anand Gopal; Joshua Wallach; Saloni Shah; Carl Regillo; Joseph Ross

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3070. doi:

ARVO Annual Meeting Abstract July 2019

Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

Brandon Kuley; Philip Storey; Maitri Pancholy; Anthony Obeid; James Murphy; Jake Goodman; Turner D Wibbelsman; Carl Regillo; Allen Chiang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2645. doi:

ARVO Annual Meeting Abstract July 2019

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Turner D Wibbelsman; Daniel B Calem; Anthony Obeid; Phoebe L Mellen; Michelle A. Konkoly; Michael R. Velez; Kareem Sioufi; Durga S Borkar; Ravi Pandit; Michael A. Klufas; Jason Hsu; Carl Regillo; Allen C Ho; Omesh P Gupta; Marc J. Spirn

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4057. doi:

ARVO Annual Meeting Abstract July 2019

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Jason Hsu; Anthony Obeid; Phoebe L Mellen; Turner D Wibbelsman; Michelle A. Konkoly; Michael R. Velez; Daniel B. Calem; Kareem Sioufi; Daniel Su; Philip Storey; Michael A. Klufas; Marc J. Spirn; Carl Regillo; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):80. doi:

ARVO Annual Meeting Abstract July 2018

Incidence of ocular hypertension following intravitreal injection of 2mg triamcinolone

Philip Storey; Anthony Obeid; Maitri Pancholy; Jake Goodman; Xinxiao Gao; Durga S Borkar; Daniel Su; Carl Regillo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):79. doi:

ARVO Annual Meeting Abstract July 2018

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Branch Retinal Vein Occlusion

Nadim Rayess; Ehsan Rahimy; Gui-Shuang Ying; Maria Pefkianaki; Carl Regillo; allen ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4291. doi:

ARVO Annual Meeting Abstract July 2018

Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcomes Data

Steven D Schwartz; Carl Regillo; Byron L Lam; Dean Eliott; Ninel Gregori; Jean-Pierre Hubschman; Gad Heilweil; Marc Spirn; Joseph Maguire; Rosaleen Ostrick; Lucian Del Priore; Eddy Anglade; Robert Lanza

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5004. doi:

ARVO Annual Meeting Abstract June 2017

27-gauge vitrectomy wound integrity: a randomized pilot study comparing angled versus straight entry in fluid-filled vitrectomized eyes

M. Ali Ali Khan; Alia Durrani; Jason Hsu; Carl D Regillo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2791. doi:

ARVO Annual Meeting Abstract June 2017

Optical Coherence Tomography Angiography in Hydroxychloroquine Toxicity

Priya Sharma; Maria Pefkianaki; Murtaza K Adam; Allen Ho; Jason Hsu; Joseph Maguire; Carl D Regillo; Charles G. Affel; Elizabeth Affel; Julia A Haller

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3682. doi:

ARVO Annual Meeting Abstract June 2017

Comparison of chandelier-assisted scleral buckling versus traditional scleral buckling for rhegmatogenous retinal detachment repair at an academic teaching center

Katherine E Talcott; Anthony Obeid; Allen Chiang; Sunir Garg; Allen Ho; Carl D Regillo; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4154. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies

Optical Coherence Tomography Findings in Eyes with Spontaneous Reattachment of Macula-off Traction Retinal Detachments

Refractive Error Change During Diabetic Macular Edema Treatment: A Post Hoc Analysis of the DRCR Protocol T Trial

Efficacy, durability and safety of KSI-301 antibody biopolymer conjugate in wet AMD – Year 1 primary endpoint results from the pivotal DAZZLE study

Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 for neovascular AMD (OPTIC Trial)

Retinal Displacement Following Incisional Rhegmatogenous Retinal Detachment Repair

Development of cystoid macular edema following rhegmatogenous retinal detachment surgery

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Anatomic and visual outcomes of primary retinal detachment in younger adults: a report from the multicenter Primary Retinal Detachment Outcomes (PRO) Study

Retinal Detachment Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty

Characteristics of Clinical Studies Evaluating Off-Label Indications for Novel FDA-Approved Therapeutics in Ophthalmology

Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Incidence of ocular hypertension following intravitreal injection of 2mg triamcinolone

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Branch Retinal Vein Occlusion

Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcomes Data

27-gauge vitrectomy wound integrity: a randomized pilot study comparing angled versus straight entry in fluid-filled vitrectomized eyes

Optical Coherence Tomography Angiography in Hydroxychloroquine Toxicity

Comparison of chandelier-assisted scleral buckling versus traditional scleral buckling for rhegmatogenous retinal detachment repair at an academic teaching center

To View More...

You must be signed into an individual account to use this feature.